Greater Precision for Transformative Drug Discovery | Biognosys
Contact us Helpdesk

Greater Precision for Transformative Drug Discovery

Target identification and validation are key challenges in drug discovery. Limited Proteolysis Mass Spectrometry (LiP-MS) is a robust, reliable way to identify on- and off-target binding effects throughout the proteome, elucidate mechanisms of action, and reveal potential toxicities.

 

View Application Note

Back to Resources overview